Investigational Drug Details
| Drug ID: | D511 |
| Drug Name: | Verinurad |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB11873 |
| DrugBank Description: | Verinurad has been used in trials studying the basic science and treatment of Gout, Gout and Hyperuricemia, and Gout and Asymptomatic Hyperuricemia. |
| PubChem ID: | 54767229 |
| CasNo: | 1352792-74-5 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CC(C)(SC1=CC=NC=C1C1=C2C=CC=CC2=C(C=C1)C#N)C(O)=O |
| Structure: |
|
| InChiKey: | YYBOLPLTQDKXPM-UHFFFAOYSA-N |
| Molecular Weight: | 348.42 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0403 | NCT04987242 | PHASE2 | COMPLETED | NO | 2021-07-16 | 2023-06-22 | Details |
| L0466 | NCT03603938 | UNKNOWN | NO | 2018-11-01 | 2018-07-27 | Details | |
| L0890 | NCT00358722 | PHASE2 | TERMINATED | NO | 2006-07 | 2009-08-10 | Details |
| L0891 | NCT01222234 | COMPLETED | YES | 2010-10 | 2016-05-16 | Details | |
| L0921 | NCT01242904 | PHASE2 | COMPLETED | NO | 2010-09-30 | 2017-08-28 | Details |
| L3299 | NCT02623465 | PHASE1 | WITHDRAWN | NO | 2018-01 | 2017-07-13 | Details |
| L7213 | NCT01076647 | PHASE3 | COMPLETED | YES | 2010-03 | 2017-03-06 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|